AIDS

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	102
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	89
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	75
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	44
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	43
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	42
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	40
Trends in population HIV viral suppression: a longitudinal analysis	39
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	34
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	34
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	32
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	31
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	31
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	31
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	30
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	29
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	29
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	28
Social context and tracing household wealth over time in rural Uganda 1994–2018	28
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	27
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	27
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	26
Life expectancy of people with HIV on antiretroviral therapy in Spain	26
Real world use of dolutegravir two drug regimens	24
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	24

Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	24
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	24
Hiv and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex (YWSS) in rural south africa: a population-based cohort study	24
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	24
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	23
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	23
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	22
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	22
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	22
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	21
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	21
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	21
Association between low bone mass and fracture prevalence among children living with HIV in Africa	21
Fatty liver disease in children living with HIV: a ghostly iceberg	20
Incident depression among Medicare beneficiaries with disabilities and HIV	20
Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa	20
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	20
Anal neoplasia: prevention or treatment?	20
Age-associated dementia among older people aging with HIV in the United States: a modeling study	20
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	20
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	19
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	19
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	18
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?	18
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	18
Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985–2019	18
Increased risk of false-positive HIV ELISA results after COVID-19	17
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	17
Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients	17
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	17
Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV	17
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	17
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	17
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial	17
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes	16
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus	16
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	16
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	16
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	16
Coordination of inflammatory responses in children with perinatally acquired HIV infection	16
Obesity in HIV infection: host-pathogen interaction	16
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	15
Sexually transmitted infections in the preexposure prophylaxis era	15
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	15
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	15
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	15
Predictors of intact HIV DNA levels among children in Kenya	15
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	15
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	15
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	15

Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	15
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	15
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	14
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	14
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	14
A note of thanks to our reviewers	14
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	14
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	14
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	14
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	14
Ambient air pollution is associated with vascular disease in Ugandan HIV-positive adolescents	14
Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis	14
The relationship between HIV and reading performance for children in Tanzania	14
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	14
Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of age	13
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	13
Poverty and protection: the relationship between multidimensional poverty, social protections interventions, and HIV viral load	13
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	13
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	13
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers	13
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	13
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	13
Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries	13
Global health solidarity in the HIV and hypertension disease response	12
Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	12
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection	12
Racial disparities in cancer risk among MSM with HIV in the United States	12
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	12
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	12
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	12
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	12
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among MSM in China	12
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	12
Housing is harm reduction	12
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	12
Children who are HIV-exposed and uninfected: evidence for action	12
HIV and race are independently associated with endothelial dysfunction	12
The incidence and dynamic risk factors of chronic kidney disease among people with HIV	12
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	12
Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy	12
HIV-positive Ukrainian refugees in the Czech Republic	11
A new smoking cessation ‘cascade’ among women with or at risk for HIV infection	11
Auditory and cognitive function in older adults living with and without HIV	11
Caregiver fears and assumptions about child HIV status drive not testing children for HIV	11
A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders	11
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	11
Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs	11
Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc	11
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	11
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	11
Is it time to retire efavirenz as a first-line option worldwide?	11
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period	11
COVID-19 in Africa: preexisting immunity and HIV	11
Associations between HIV serostatus and coronary artery plaque volume progression	11
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	11
Risk and predictors of penile cancer in US Veterans with HIV	11
When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV	11
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	11
Cervical cancer screening in women living with HIV: an audit of clinical care	11
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	10
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	10
Factors associated with survival in patients with lymphoma and HIV	10
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	10
Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population	10
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	10
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	10
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV	10
Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis	10
Deciphering HIV vaccine-induced antibody response according to ethnicity	10
Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy	10
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	10
Fungal diseases are not in the radar of main international HIV conferences	10
The HIV-2 proviral landscape is dominated by defective proviruses	10
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	10
Addressing the burden of HIV-associated chronic lung disease in West Africa	10
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	9
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	9
HIV and mpox: a rapid review	9
Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection	9
Transplantation of kidneys from donors with HIV: are we there yet?	9

Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	9
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	9
Initial antiretroviral therapy regimen and risk of heart failure	9
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	9
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	9
The application of new metrics for understanding trends in undiagnosed HIV among key populations	9
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	9
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	9
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	9
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption	9
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	9
Cytokines in HIV infection: authors’ reply	9
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	9
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	9
Food insecurity likely contributes to frailty in people with HIV	9
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	9
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	9
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	9
Cardiovascular risk score associations with frailty in men and women with or at risk for HIV	9
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	9
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy	9
Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies	9
Self-injurious unnatural death among Veterans with HIV	9
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	9
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3	9
Distinct antibody profiles in HLA-B ∗ 57 + , HLA-B ∗ 57 − HIV controllers and chronic progressors	8
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder	8
Years of life lost to cancer among the United States HIV population, 2006–2015	8
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV	8
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	8
TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection	8
Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women	8
Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	8
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
Care interruptions and mortality among adults in Europe and North America	8
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	8
Contribution of HIV transmission bursts to future HIV infections	8
Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort	8
Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study	8
Incidence of high blood pressure among Kenyan adults with HIV	8
Clinical decision support systems to guide healthcare providers on HIV testing	8
Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	8
Dolutegravir-induced neural tube defects in mice are folate responsive	8
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	8
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV	8
On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: Why Ending the HIV Epidemic must address these factors for success	8
Baseline HIV drug-resistance testing: 12 US jurisdictions, 2014–2019	8
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	8
Cost of improved test and treat strategies in Indonesia	7
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability	7
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	7
From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017–2020	7
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV	7
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?	7
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	7
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	7
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	7
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
AIDS: changes in leadership	7
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	7
Weight loss associated with semaglutide treatment among people with HIV	7
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Left behind? A longitudinal analysis of need for PrEP services among middle-aged and older adults in South Africa	7
Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	7
Human herpes virus 8-related illness: still with us	7
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	7
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	7
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	7
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	7
Intersectional stigmas are associated with lower viral suppression rates and antiretroviral therapy adherence among women living with HIV	7
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	7
Differential genome-wide associated variants and enriched pathways of ECG parameters among people with versus without HIV	7
Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000–2019	7
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	7
Association between HIV and cancer risk	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	7